Oliver Wright

Oliver Wright is a Clinical Development Director at Novartis Oncology, where they are responsible for setting the global strategy for clinical development plans targeting chronic lymphocytic leukemia and non-Hodgkin’s lymphoma. Previously, they held various roles at Eli Lilly and Company and GSK Oncology, including Clinical Research Associate and European/International Regional Study Manager. Oliver possesses extensive experience in clinical development, regulatory inspections, and cross-functional collaboration, demonstrating exceptional leadership and operational management skills. They are currently seeking new opportunities in the field.